Differential pro-apoptotic effect of allicin in oestrogen receptor-positive or -negative human breast cancer cells

被引:6
|
作者
Kim, Kyung-Ho [1 ]
Cho, Seong-Jun [2 ]
Kim, Byung-Oh [3 ]
Pyo, Suhkneung [1 ]
机构
[1] Sungkyunkwan Univ, Sch Pharm, Suwon, Gyeonggi Do, South Korea
[2] Korea Hydro & Nucl Power Co LTD, KHNP Radiat Hlth Inst, Seoul, South Korea
[3] Kyungpook Natl Univ, Sch Food Sci & Biotechnol, Coll Agr & Life Sci, Daegu, South Korea
关键词
Allicin; Apoptosis; Oestrogen receptor; Breast cancer; ER; MAPK; DIALLYL TRISULFIDE; CHEMOTHERAPY; ACTIVATION; ALPHA;
D O I
10.1016/j.jff.2016.06.019
中图分类号
TS2 [食品工业];
学科分类号
0832 ;
摘要
Allicin is known to induce apoptosis and inhibit tumourigenesis in various carcinoma cells. However, the precise mechanism of allicin-induced apoptosis remains unclear in human breast cancer cells. Here we found that ER alpha-MDA-MB-231 cells were more sensitive to allicin-induced apoptosis as compared with ER alpha(+)MCF7 cells. We also found that allicin induced reactive oxygens species (ROS)-mediated and caspase-dependent apoptosis in MDA-MB-231 cells, but not in MCF7 cells. Additionally, we showed the p38 and JNK pathways were involved in allicin-induced apoptosis. Furthermore, we demonstrated that ER alpha-knockdown increased cell growth suppression and apoptosis of MCF7 cells in response to allicin, whereas ER alpha-overexpression decreased cell growth suppression and apoptosis of MDA-MB-231 cells, implicating that ER alpha has a protective role during allicin-induced apoptosis. Collectively, these findings suggest that allicin induces differential apoptotic pathways through MAPK activated by ROS-dependent or -independent signalling pathway in breast cancer cells. (C) 2016 Elsevier Ltd. All rights reserved.
引用
收藏
页码:341 / 353
页数:13
相关论文
共 50 条
  • [21] Implications of obesity and insulin resistance for the treatment of oestrogen receptor-positive breast cancer
    Javed, Sohail Rooman
    Skolariki, Aglaia
    Zameer, Mohammed Zeeshan
    Lord, Simon R.
    BRITISH JOURNAL OF CANCER, 2024, 131 (11) : 1724 - 1736
  • [22] Effects of fulvestrant in premenopausal women with oestrogen receptor-positive primary breast cancer
    Robertson, J.
    Semiglazov, V.
    Gee, J.
    Armstrong, J.
    EJC SUPPLEMENTS, 2004, 2 (03): : 73 - 74
  • [23] Prognostic stratification of oestrogen receptor-positive HER2-negative lymph node-negative class of breast cancer
    Rakha, Emad A.
    Agarwal, Devika
    Green, Andrew R.
    Ashankyty, Ibraheem
    Ellis, Ian O.
    Ball, Graham
    Alaskandarany, Mohammed A.
    HISTOPATHOLOGY, 2017, 70 (04) : 622 - 631
  • [24] RB in breast cancer: Differential effects in estrogen receptor-positive and estrogen receptor-negative disease
    Musgrove, Elizabeth A.
    Sutherland, Robert L.
    CELL CYCLE, 2010, 9 (23) : 4607 - 4607
  • [25] The oestrogen receptor-negative/progesterone receptor-positive breast tumour: a biological entity or a technical artefact?
    Rhodes, A.
    Jasani, B.
    JOURNAL OF CLINICAL PATHOLOGY, 2009, 62 (01) : 95 - 96
  • [26] Estrogen receptor-negative/progesterone receptor-positive and her-2-negative breast cancer might no longer be classified as hormone receptor-positive breast cancer
    Zheng, Hongjuan
    Ge, Chenyang
    Lin, Haiping
    Wu, Lunpo
    Wang, Qinghua
    Zhou, Shishi
    Tang, Wanfen
    Zhang, Xia
    Jin, Xiayun
    Xu, Xifeng
    Hong, Zhongwu
    Fu, Jianfei
    Du, Jinlin
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2022, 27 (07) : 1145 - 1153
  • [27] Estrogen receptor-negative/progesterone receptor-positive and her-2-negative breast cancer might no longer be classified as hormone receptor-positive breast cancer
    Hongjuan Zheng
    Chenyang Ge
    Haiping Lin
    Lunpo Wu
    Qinghua Wang
    Shishi Zhou
    Wanfen Tang
    Xia Zhang
    Xiayun Jin
    Xifeng Xu
    Zhongwu Hong
    Jianfei Fu
    Jinlin Du
    International Journal of Clinical Oncology, 2022, 27 : 1145 - 1153
  • [28] Androgen receptor-positive, triple-negative breast cancer
    Gucalp, Ayca
    Traina, Tiffany A.
    CANCER, 2017, 123 (10) : 1686 - 1688
  • [29] Pro-apoptotic activity of ergosterol derivatives in human prostate cancer cells
    Russo, A.
    Cardile, V
    Piovano, M.
    Frasca, G.
    Espinoza, C. L.
    Garbarino, J.
    PLANTA MEDICA, 2008, 74 (09) : 961 - 961
  • [30] Characterization of antiandrogen resistant androgen receptor-positive triple negative breast cancer cells
    Bhattacharya, Saswati
    Siegel, Noah
    O'Regan, Ruth
    CANCER RESEARCH, 2020, 80 (04)